Skip to main content
Have a personal or library account? Click to login
Chronic Kidney Disease – Chronic Liver Disease. An Immunologic Cross-talk Cover

Chronic Kidney Disease – Chronic Liver Disease. An Immunologic Cross-talk

Romanian Journal of Internal Medicine
Volume 53 (2015): Issue 1 (March 2015)
By: ,  ,  ,  ,  ,   and    
Open Access
|Oct 2015
References

References

  1. 1. BALMASOVA IP, YUSHCHUK ND, MINBAEV OA, ALLA NR, MALOVA ES, ZHONG JE, SHI Z, GAO CI. Immunopathogenesis of chronic hepatitis. World J. Gastroenterol. 2014, 20, 39, 14156-14171.
    Search in Google Scholar
  2. 2. TREPOC CHAN HL, LOK A. Hepatitis B virus infection. Lancet. 2014, 384, 9959, 2053-2063.
    Search in Google Scholar
  3. 3. LIU XR, SHEN YH. Membranous glomerulopathy associated with hepatitis B virus infection. HKig Pediatr (newseries), 2002, 13, 22-29.
    Search in Google Scholar
  4. 4. VENKATASESHAN VS, LIEBERMAN K, KIM DU, THUNG S, DIUMAN S. Hepatitis B associated glomerulonephritis: pathology, pathogenesis and clinical course. Medicine (Baltimore) 1990, 69, 4, 200-216.
    Open DOISearch in Google Scholar
  5. 5. ZHANG JH, LI ZHOU N. Is there a hepatitis B virus-assocated glomerulonephritis? Identification of HBsAg, HBc and HBcAg with monoclonal antibodies. Chin. Med. J. (Engl)1989, 108, 7, 496-504.
    Search in Google Scholar
  6. 6. LIN CY, LIN CS, CHANG GH. Defect of cell mediated immune response against hepatitis;an indication for pathogenesis of hepatitis B virus-associated membranous nephropathy. Nephron 1994 ,765,176-185.
    Open DOISearch in Google Scholar
  7. 7. PENG G, Li S, WU W, SUN Z, CHEN Y, CHEN Z. Circulating CD4+CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008, 123, 57-65.
    Search in Google Scholar
  8. 8. LU H, ZHU H, ZHOU Y. S gene mutation of HBV in children with HBV-associated glomerulonephritis. Virol. J. 2012, 9, 59, doi 10.IV 86/1743/422Y-9-5.
    Search in Google Scholar
  9. 9. HUI D, YAN V, WEI Y, RUIXIZ M, GUANGIU G. Significance of mutations in hepatitis B virus X gene for pathogenesis HBV-associated glomerulonephritis. Acta Virol. 2014, 58, 3, 278-281.
    Search in Google Scholar
  10. 10. LAI KH, HO RT, TAM JS, LAI FM. Detection of hepatitis B virus DNA and RNA in kidney of HBV related glomerulonephritis. Kidney Int. 1996, 50, 6, 1965-1997.
    Search in Google Scholar
  11. 11. El-SERAQ HR, HAMPEL H, YEH E. RABENECK I. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002, 36, 6, 1439-1445.
    Open DOISearch in Google Scholar
  12. 12. MOE SM, PAMPALONE A, OFNER S, ROSEMAN M, TED E, HUI SL. Association of hepatitis C virus infection with prevalence and development of kidney diseases. Am J. Kidney Dis 2008, 51, 6, 885-892.
    Open DOISearch in Google Scholar
  13. 13. FABRIZI F, MARTIN P, DIXIT V, MESSA P. Hepatitis virus infection and kidney disease: a meta analysis. Clin J. Am Soc Nephrol. 2012, 7, 4, 549-557.
    Search in Google Scholar
  14. 14. CHARTER Ed, DUSTIN LB. Hepatitis C virus-induced cryoglobulinaemia. Kidney Int 2009, 76, 8, 818-824.
    Open DOISearch in Google Scholar
  15. 15. FABRIZI F, MESSA P, MARTIN P. Novel evidence on hepatitis C virus-associated glomerular disease. Kidney Int. 2014, 86, 3, 466-469.
    Search in Google Scholar
  16. 16. TANA MM, HELLER T. Autoantibodies in hepatitis C: red flag or bystander. J Pediat Gastroenterol. Nutr. 2013, 56, 3, 243.
    Search in Google Scholar
  17. 17. FERRY S, MURATORI L, LENZI M. HCV and auto immunity. Curr. Pharm. Dis 2008, 14, 1672-1685 (Pub Med).
    Open DOISearch in Google Scholar
  18. 18. MARCEAU G, LAPIERRE P, BELAND K, SAUDEYENS H, ALVAREZ F. LKM and autoantibodies in chronic hepatitis C infections. A case of molecular mimicry? Hepatology 2005, 42, 675-682.
    Open DOISearch in Google Scholar
  19. 19. STOKES MB. Immune complex glomerulonephritis in patients with hepatitis C. Saudi J Kidney Dis Transpl (Serial Online). 2000, 11, 3, 396-404.
    Search in Google Scholar
  20. 20. HO V, CHEN J. Hepatitis XC virus associated glomerulonephritis in: PRZONACAR S, An update on glomerulonephritis. Clinical and treatment aspects. 2011. In tech Shanghai, China.
    Open DOISearch in Google Scholar
  21. 21. ISKANDAR SS, HERRERA GA. Glomerulopathies with organized deposits. Semin Diagn Pathol 2002, 19, 3, 116-132.
    Search in Google Scholar
  22. 22. SANSANNO D, LAULETTA G, MONTRONE M, GRANDALIANO G, SCHENA FP, DAMMACCO F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005, 140, 3, 498-506.
    Open DOISearch in Google Scholar
  23. 23. CAO Y, ZHANG Y, WANG S, ZOU W. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant. 2009; 24, 9, 2745-2751.
    Search in Google Scholar
  24. 24. KONG D, WU D, VAN T, LI T, ZU S, CHEN F, KIN X, LOU C. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection. Int. J. Infect Dis 2013, 17, 7, e 535-e538.
    Open DOISearch in Google Scholar
  25. 25. WHO. Hepatitis C. Fact sheet update. April 2014.
    Search in Google Scholar
  26. 26. JOHNSON RJ, GRETCH DR, COUSER WG, ALPERS CE, WILSON J, CHUNG N et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl. J. Med 1993, 328, 7, 465-470.
    Open DOISearch in Google Scholar
  27. 27. QUARTUCCIO L, SOARDO GE, ROMANO G, SCOTT CA, De MARCHE G et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia; efficacy and safety in the absence of steroids. Rheumatology, 2006, 45, 7, 842-846.
    Open DOISearch in Google Scholar
  28. 28. HO V, CHEN J. Hepatitis C virus associated glomerulonephritis in: PRABHAKAR SEd. An update on glomerulopathies. Clinical and treatment aspects 2011. In: Tech Shanghai, China.
    Open DOISearch in Google Scholar
  29. 29. SUGIMOTO K, TAKEI. Clinicopathological features of non-alcoholic fatty liver disease. Hepatol Res 2011, 10, 911-920.
    Open DOISearch in Google Scholar
  30. 30. AHN AL, CHOI JK, KIM MN, KIM SA, OH EJ, KUCON HJ, CHO DY. Non-alcoholic fatty liver disease and chronic liver disease in Koreans aged 50 years or older. Korean J. Fam Med. 2013, 34, 3, 199-205.
    Search in Google Scholar
  31. 31. SIROTA JC, McFANN K, TARGHER G, CHONCHOL M, JALAL DI. Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994. Am J Nephrol. 2012, 36, 5, 466-71. doi: 10.1159/000343885.
    Open DOISearch in Google Scholar
  32. 32. TARGER G, CHONCHOL M, ZOPPINI G, ABATERUSSO C, DONORA E. Risk of chronic kidney disease in patients with non-alcholic fatty disease. Is there a link ? J Hepatol 2011, 54, 5, 1020-1029.
    Open DOISearch in Google Scholar
  33. 33. MUSSO G, GAMBINO R, TABIBIAN JH. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. Plos Med. 2014, 11, 7: e 1001680 doi 10.1374/journal p med 1001680 e collection 2014.
    Search in Google Scholar
  34. 34. BULUM T, DUVNJAK L. Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes. Acta Med Croatia 2011, 65, Supp l, 3, 6-10, Pub Med.
    Search in Google Scholar
  35. 35. YILMAZ Y, ALAHDAB Y, YONAL O. Microalbuminuria in non-diabetic patients with nonalcoholic fatty liver disease associated with liver fibrosis. Metabolism 2010, 59, 9, 1327-1330.
    Open DOISearch in Google Scholar
  36. 36. ADHIKARI KB, OREN T. Non-alcoholic fatty liver disease (NAFLD) and immune response. J Inst Med 2010, 3, 43-53.
    Open DOISearch in Google Scholar
  37. 37. IX JH, SHARMA K. Mechanisms linking obesity, chronic kidney disease and fatty liver disease, the role of fetuin A, adiponectin and AMPK. J Am Soc Nephrol 2010, 21, 3, 406-412.
    Open DOISearch in Google Scholar
  38. 38. MOURALIDANE A, SOEDA J, VISCONTI-PUGMIRE, SAMULELSON A, TOMBO J, MARAGKOUDAKI X. Maternal obesity programs offspring non-alcoholic fatty liver disease via innate immune disjunction in mice. Hepatology 2013, 52, 128-138.
    Open DOISearch in Google Scholar
  39. 39. AMOR J, CHABO C, WAGET A, KLOPP P, VACHOU C, BEMUDEZ-HUNARAN LG. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes, molecular mechanisms and probiotic treatment. EMBO, Mol Med. 2011, 3, 559-572.
    Search in Google Scholar
  40. 40. MELI R, RASO GM, CALIGNANO A. Role of innate response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools. Front Immunol 2014/doi: 103389/ fimmu 2014-00177.
    Open DOISearch in Google Scholar
  41. 41. ORLIC I, MIKOLASEVIC I, BAGIC Z, RACUL S, STIMAC D MILIC. Chronic kidney disease and non-alcoholic liver disease - is there a link? Gastroenterol. Res. Pract. 2014, doi org/10-1155/2014/847539.
    Open DOISearch in Google Scholar
  42. 42. JIN K, NORIS K, VAZIRI ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant. 2013, 28, 2, 313-320.
    Search in Google Scholar
  43. 43. YANG M, GONG S, YE SQ, LYMAN B, CHEN P, DY L. Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients 2014, 6, 1, 4691-4705.
    Open DOISearch in Google Scholar
  44. 44. NEWELL CC. Cirrhotic glomerulonephritis, incidence, morphology, clinical features and pathogenesis. Am. J. Kidney Dis. 1987, 9, 3, 183-190.
    Search in Google Scholar
  45. 45. POURIS S, FEEHALLY J. Glomerular IgA deposition in liver disease. Nephrol Dial Transplant, 199, 14, 10, 2279-2282.
    Open DOISearch in Google Scholar
  46. 46. TISSANDIE E, MORELLE W, BERTHELOT L, VRTOVSNIK F, DAUGAS M et al. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89 -IgA complexes common mechanisms for distinct disease. Kidney Int 2011, 80, 12, 1352-1363.
    Open DOISearch in Google Scholar
  47. 47. KALAMBOKIS G, CRISTOU I, STEFANOU D, ARKEUMANI E, TSIANOS EV. Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol, 2017, 13 13, 43, 5783-5786.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/rjim-2015-0001 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English, Romanian
Page range: 3 - 12
Submitted on: Jan 22, 2015
Published on: Oct 7, 2015
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Keywords:
chronic kidney desease,
chronic liver desease,
immune complexes
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2015 Gh. Gluhovschi, Ligia Petrica, I. Sporea, Manuela Curescu, Silvia Velciov, Cristina Gluhovschi, R. Timar, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 53 (2015): Issue 1 (March 2015)
Next article